In caso di infiammazione cronica sistemica In sintesi: il candidato ideale per luso del BPC-157 uno con problematiche muscoloscheletriche, infiammazione cronica a livello gastrointestinale e infortuni neurovascolari.
Huang T et al., Drug Des Devel Ther, 2015
The test reveals genetic predispositions in lipid and metabolic pathways (FTO, MC4R, GIPR, GLP1R variants)
Participants who took glutathione had: Despite these drops, subjective symptoms like headaches didnt improve muchlikely because other factors (dehydration, inflammation) still play a role
Biochem Biophys Res Commun (2011) 415:6326
published in Current Neuropharmacology (2016) demonstrated that BPC-157 enhances the expression of VEGF by up to 3.5-fold, significantly accelerating the formation of new capillaries